Find uplifting stories about heroes, innovations, and solutions
9 results for "psychedelics"
Researchers analyzed over 500 brain scans and discovered a common "neural fingerprint" across LSD, psilocybin, and three other psychedelics. This breakthrough could strengthen clinical trials testing these substances for depression and PTSD.
Just one week of intensive meditation produced brain changes that scientists usually see only with psychedelic drugs. Researchers at UC San Diego measured dramatic shifts in brain connectivity, immunity, and natural pain relief.
Bipartisan legislation introduced by veteran senators would create a dedicated office to bring emerging mental health therapies, including psychedelics, to veterans struggling with PTSD and depression. The bill sets up infrastructure now so veterans can access innovative treatments the moment they receive FDA approval.
A Colorado woman battling stage III uterine cancer joined a groundbreaking study combining psilocybin with therapy to treat anxiety and depression. The results transformed how she lives with her diagnosis.
A Johns Hopkins study found that a single dose of psilocybin helped smokers quit at six times the rate of nicotine patches. It's the first potential new smoking cessation medication in 20 years.
A groundbreaking trial in London shows that DMT, the shortest-acting psychedelic drug, helped nearly half of depression patients feel better within just one week. The fast-acting treatment could transform care by letting patients go home hours after treatment instead of days.
New research shows psychedelics like psilocybin and MDMA could help people with PTSD recover in hours instead of months by actually rewiring trauma-affected brain systems. Clinical trials reveal 67% of patients no longer met PTSD criteria after MDMA-assisted therapy, offering hope to 12 million Americans struggling with the condition.
A Tibetan lama with 54,000 hours of meditation experience showed identical brain patterns during deep meditation and a low dose of psychedelics. The discovery could help scientists understand consciousness and make meditation benefits more accessible.
A major clinical trial found that caffeine worked better than tiny doses of LSD for treating depression, challenging years of Silicon Valley hype. The research suggests microdosing's benefits may be mostly placebo effect.